Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
23 Results for "
ATRA
" in MedChemExpress (MCE) Product Catalog:
Products (23)
23 Results for "ATRA" in MCE Product Catalog:
146
146 Cited Publications
Synonyms: Vitamin A acid; all-trans-Retinoic acid; ATRA
Synonyms: Vitamin A acid (Standard); all-trans-Retinoic acid (Standard); ATRA (Standard)
Synonyms: Vitamin A acid (GMP); all-trans-Retinoic acid (GMP); ATRA (GMP)
Synonyms: RP 73401; RPR 73401
Target:
Domaines de recherche:
Piclamilast (RP 73401) is a phosphodiesterase 4 (PDE4) inhibitor, with IC50 values of 16 nM and 2 nM in pig aorta and eosinophil soluble, respectively .
Cat. No.: HY-NP004
Synonyms: CVF
Synonyms: Biotin-ATRA-conjugate
Target:
Cat. No.: HY-14649S4
CAS No.: 78996-15-3
Synonyms: Vitamin A acid-d5; all-trans-Retinoic acid-d5; ATRA-d5
Target:
Domaines de recherche:
ER 50891 is a RARα antagonist. ER 50891 can significantly antagonize the inhibitory effect of all-trans retinoic acid (ATRA) on the total cell metabolic activity and proliferation of MC3T3-E1 preosteoblasts. ER 50891 rescues ATRA-inhibited osteocalcin (OCN) expression and extracellular matrix mineralization, and suppresses alkaline phosphatase (ALP) activity synergistically. ER 50891 can be used for the study of osteoporosis related to ATRA-induced inhibition of osteoblastogenesis .
Cat. No.: HY-D1190
CAS No.: 198696-03-6
Cat. No.: HY-108531A
Pureté: 99.86%
ER 50891 quarterhydrate is a RARα antagonist. ER 50891 can significantly antagonize the inhibitory effect of all-trans retinoic acid (ATRA) on the total cell metabolic activity and proliferation of MC3T3-E1 preosteoblasts. ER 50891 rescues ATRA-inhibited osteocalcin (OCN) expression and extracellular matrix mineralization, and suppresses alkaline phosphatase (ALP) activity synergistically. ER 50891 can be used for the study of osteoporosis related to ATRA-induced inhibition of osteoblastogenesis .
Cat. No.: HY-169863
CAS No.: 2324152-25-0
Target:
Domaines de recherche:
DC360 is a synthetic retinoid analogue of all-trans retinoic acid (ATRA) which induces RARβ expression. DC360 can be utilized in characterization of retinoid signalling pathways .
Cat. No.: HY-118761
CAS No.: 13100-69-1
Synonyms: 5,6-epoxy ATRA; 5,6-epoxy RA
Target:
Domaines de recherche:
all-trans-5,6-epoxy Retinoic acid (5,6-epoxy RA) is an agonist of all isoforms of the retinoic acid receptor (RAR; EC50s=77, 35, and 4 nM for RARα, RARβ, and RARγ, respectively). 5,6-epoxy RA (1 μM) also induces growth arrest of MCF-7 and NB4 cells in vitro. It is a natural metabolite of all-trans retinoic acid, which is a metabolite of vitamin A.
Synonyms: Vitamin A acid-d6; all-trans-Retinoic acid-d6; ATRA-d6
Cat. No.: HY-111839
CAS No.: 135325-47-2
Synonyms: CRABP-II ligand 1
Domaines de recherche:
ATRA-hydroxyimino (CRABP-II ligand 1), the Retinoic acid (ATRA)-based moiety, binds to cIAP1 ligand (Bestatin) via a linker to form SNIPER to degrade CRABP-II in IMR-32 cells .
Cat. No.: HY-123647
CAS No.: 53126-64-0
Category:
Cat. No.: HY-12887R
CAS No.: 144035-83-6
Synonyms: RP 73401 (Standard); RPR 73401 (Standard)
Domaines de recherche:
Piclamilast (Standard) is the analytical standard of Piclamilast. This product is intended for research and analytical applications. Piclamilast (RP 73401) is a phosphodiesterase 4 (PDE4) inhibitor, with IC50 values of 16 nM and 2 nM in pig aorta and eosinophil soluble, respectively .
Cat. No.: HY-14649S5
CAS No.: 154461-49-1
Synonyms: Vitamin A acid-d3; all-trans-Retinoic acid-d3; ATRA-d3
Cat. No.: HY-14649S6
CAS No.: 3041101-53-2
Synonyms: Vitamin A acid-d3-1; all-trans-Retinoic acid-d3-1; ATRA-d3-1
Cat. No.: HY-182728
CAS No.: 110952-26-6
Target:
Domaines de recherche:
CD564 (Compound 11b) is a cytochrome P450 CYP26A1 and CYP26B1 inhibitor, with IC50 values of 1.63 μM and 0.52 μM, respectively. Cytochrome P450 CYP26 enzymes clear all-trans retinoic acid (atRA) .
Cat. No.: HY-184097
CAS No.: 3098670-37-9
MS9117 is a PROTAC molecule that targets and degrades LSD1/BHC110 by recruiting CRBN. MS9117 effectively increases the level of histone H3 lysine 4 monomethylation. MS9117 significantly inhibits the proliferation and colony formation of cancer cells, promotes their myeloid differentiation, and enhances the sensitivity of non-acute promyelocytic leukemia-type AML cells to all-trans retinoic acid (ATRA) .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
